Literature DB >> 33252485

HIV in Iran: onset, responses, and future directions.

SeyedAhmad SeyedAlinaghi1, Leila Taj1, Elham Mazaheri-Tehrani1, Sara Ahsani-Nasab1, Negin Abedinzadeh1, Willi McFarland2, Minoo Mohraz1, Ali Mirzazadeh2,3.   

Abstract

Iran, a country in the Middle East and North Africa (MENA) region, has been actively involved in the fight against HIV/AIDS over the past three decades. The unique features of the HIV epidemic in Iran are reflected by the modes of transmission and its recent changes to improve management and prevention programs. In this review, we recount the initial onset and subsequent spread of HIV infection in Iran, beginning with the first case diagnosed to the ongoing responses and most recent achievements in controlling this epidemic. Although in the MENA region, Iran is one of the pioneers in implementing pertinent policies including harm reduction services to decrease HIV incidence, drug injection still continues to be the major risk of infection. In line with other nations, the programs in Iran aim at the UNAIDS 90-90-90 targets (UNAIDS 90-90-90 global targets to end the AIDS epidemic by 2020: by 2020, 90% of all people living with HIV will know their HIV status; 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy; and 90% of all people receiving antiretroviral therapy will have viral suppression) and to eliminate mother-to-child HIV transmission. In this article, we discuss the strengths and shortcomings of the current HIV programs and offer suggestions to provide a better perspective to track and respond to the HIV epidemic. More generally, our account of the national religious and cultural circumstances as well as obstacles to the approaches chosen can provide insights for decision-makers in other countries and institutions with comparable settings and infrastructures.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33252485      PMCID: PMC7924262          DOI: 10.1097/QAD.0000000000002757

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  52 in total

Review 1.  Evidence of HIV epidemics among non-injecting drug users in Iran: a systematic review.

Authors:  Masoumeh Amin-Esmaeili; Afarin Rahimi-Movaghar; Ali-Akbar Haghdoost; Minoo Mohraz
Journal:  Addiction       Date:  2012-06-15       Impact factor: 6.526

2.  The HIV treatment cascade in people living with HIV in Iran in 2014: Mixed-method study to measure losses and reasons.

Authors:  Nima Ghalehkhani; Behnam Farhoudi; Mohammad Mehdi Gouya; Hamid Sharifi; SeyedAhmad SeyedAlinaghi; Kianoush Kamali; Noushin Fahimfar; Zahra Rajabpour; Amin Doosti-Irani; Abbas Sedaghat; Ali Mirzazadeh
Journal:  Int J STD AIDS       Date:  2019-09-27       Impact factor: 1.359

3.  Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran.

Authors:  P Kheirandish; S A Seyedalinaghi; M Hosseini; M R Jahani; H Shirzad; M Foroughi; M R Seyed Ahmadian; H Jabbari; M Mohraz; W McFarland
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

4.  Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran.

Authors:  Behnam Farhoudi; SeyedAhmad SeyedAlinaghi; Payam Tabarsi; Minoo Mohraz; Raheleh Golrokhy; Marzieh Farnia; Mohammad Shahbazi; Ramin Alasvand; Bahman Ebrahimi; Jafar Esfehani; Mehrzad Tashakoriyan
Journal:  Infect Disord Drug Targets       Date:  2018

5.  HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.

Authors:  Jamileh Rahimi; Jaleh Gholami; Masoumeh Amin-Esmaeili; Akbar Fotouhi; Hosein Rafiemanesh; Behrang Shadloo; Afarin Rahimi-Movaghar
Journal:  Addiction       Date:  2020-01-11       Impact factor: 6.526

6.  Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010.

Authors:  Mohammad Hossein Forouzanfar; Sadaf G Sepanlou; Saeid Shahraz; Daniel Dicker; Paria Naghavi; Farshad Pourmalek; Ali Mokdad; Rafael Lozano; Theo Vos; Mohsen Asadi-Lari; Ali-Akbar Sayyari; Christopher J L Murray; Mohsen Naghavi
Journal:  Arch Iran Med       Date:  2014-05       Impact factor: 1.354

7.  Remaining Gap in HIV Testing Uptake Among Female Sex Workers in Iran.

Authors:  Mostafa Shokoohi; Atefeh Noori; Mohammad Karamouzian; Hamid Sharifi; Razieh Khajehkazemi; Noushin Fahimfar; Samira Hosseini-Hooshyar; Parvin Afsar Kazerooni; Ali Mirzazadeh
Journal:  AIDS Behav       Date:  2017-08

8.  Declining trends in HIV and other sexually transmitted infections among female sex workers in Iran could be attributable to reduced drug injection: a cross-sectional study.

Authors:  Ali Mirzazadeh; Mostafa Shokoohi; Mohammad Karamouzian; Haleh Ashki; Razieh Khajehkazemi; Apameh Salari; Negin Abedinzadeh; Seyed Alireza Nadji; Hamid Sharifi; Parvin Afsar Kazerooni; Minoo Mohraz; Ali-Akbar Haghdoost
Journal:  Sex Transm Infect       Date:  2019-12-13       Impact factor: 3.519

9.  Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.

Authors:  Fatemeh Jahanbakhsh; Junko Hattori; Masakazu Matsuda; Shiro Ibe; Seyed-Hamid R Monavari; Arash Memarnejadian; Mohammad R Aghasadeghi; Ehsan Mostafavi; Minoo Mohraz; Hossain Jabbari; Kianoush Kamali; Hossein Keyvani; Kayhan Azadmanesh; Wataru Sugiura
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Primary Health Care Strategic Key to Control HIV/AIDS in Iran.

Authors:  Hassan Joulaei; Nasrin Motazedian
Journal:  Iran J Public Health       Date:  2013-05-01       Impact factor: 1.429

View more
  8 in total

1.  Factors Associated with Baseline CD4 Cell Counts and Advanced HIV Disease among Male and Female HIV-Positive Patients in Iran: A Retrospective Cohort Study.

Authors:  Sima Afrashteh; Mohammad Fararouei; Haleh Ghaem; Mohammad Aryaie
Journal:  J Trop Med       Date:  2022-07-07

2.  Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis.

Authors:  Seyedeh-Kiana Razavi-Amoli; Abbas Alipour
Journal:  Open Forum Infect Dis       Date:  2022-09-21       Impact factor: 4.423

3.  Social Support Associated with Condom Use Behavior Among Female Sex Workers in Iran.

Authors:  Zahra Jorjoran Shushtari; Ali Mirzazadeh; SeyedAhmad SeyedAlinaghi; Seyed Ali Hosseini; Homeira Sajjadi; Yahya Salimi; Tom A B Snijders
Journal:  Int J Behav Med       Date:  2021-09-02

4.  The study of feasibility and acceptability of using HIV self-tests in high-risk Iranian populations (FSWs, MSM, and TGs): a cross-sectional study.

Authors:  Ghobad Moradi; Elnaz Ezzati Amini; Azam Valipour; Katayoon Tayeri; Parvin Afsar Kazerooni; Leila Molaeipour; Yousef Moradi
Journal:  Harm Reduct J       Date:  2022-06-03

5.  Factors Associated With Late Antiretroviral Therapy Initiation Among People Living With HIV in Southern Iran: A Historical Cohort Study.

Authors:  Sima Afrashteh; Mohammad Fararouei; Haleh Ghaem; Zahra Gheibi
Journal:  Front Public Health       Date:  2022-06-17

6.  The role of online social networks in improving health literacy and medication adherence among people living with HIV/AIDS in Iran: Development of a conceptual model.

Authors:  Azam Bazrafshani; Sirous Panahi; Hamid Sharifi; Effat Merghati-Khoei
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

7.  The effect of a theory-based educational program on southern Iranian prisoners' HIV preventive behaviors: a quasi-experimental research.

Authors:  Zahra Hosseini; Pirdad Najafi; Shokrollah Mohseni; Teamur Aghamolaei; Sara Dadipoor
Journal:  BMC Public Health       Date:  2022-07-14       Impact factor: 4.135

8.  Life loaded with threat and vulnerability: a qualitative inquiry into the experiences of HIV negative married women in serodiscordant heterosexual relationships.

Authors:  Mona Larki; Narjes Bahri; Robab Latifnejad Roudsari
Journal:  BMC Womens Health       Date:  2021-12-07       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.